000 03264nam a2200325Ia 4500
003 MX-MdCICY
005 20250626093125.0
040 _cCICY
090 _aB-21767
245 1 0 _aCurbing Key Digestive Enzymes by Three Plant Extracts for Sustainable Management of Postprandial Hyperglycemia
490 0 _aLetters in Drug Design & Discovery, 21(11), p.2015-2022, 2024
500 _aArtículo
520 3 _aAbstract: Background: Diabetes mellitus is a chronic metabolic condition marked by persistently elevated blood sugar levels. Key digestive enzymes viz. α-amylase and α-glucosidase, hydrolyze consumed carbohydrates into glucose which raises the postprandial blood glucose level in a diabetic patient. So, the development of α-amylase and α-glucosidase inhibitors procured from medicinal plants to retard starch digestion is an alternative approach for controlling type 2 diabetes mellitus. Objective: The current study aimed to evaluate the inhibitory potentials of the key digestive enzymes viz. α-amylase and α-glucosidase by the extracts of three medicinal plants; red dragon fruit (Hylocereus polyrhizus) pulp and peel, bamboo (Bambusa vulgaris) shoot, turnip (Brassica rapa L.) shoot and leaf by performing α-amylase and α-glucosidase inhibition assays in vitro. Methods: Inhibition of α-amylase activity was conducted using 3,5-dinitrosalicylic acid method, and 4- Nitrophenyl-α-D-glucopyranoside was used as a substrate to perform α-glucosidase inhibition assay in vitro. Results: Among all the selected sample extracts, red dragon fruit pulp expressed the highest percentage of α-amylase inhibition (59.73 ± 4.33 percent) at the concentration of 1000 µg/mL which is comparable to standard antidiabetic drug Acarbose (70.59 ± 2.64 percent), whereas the lowest inhibition was observed in turnip shoot extract (42.48 ± 2.10 percent) at the same concentration. In terms of α-glucosidase inhibition activity, again, red dragon fruit pulp extract demonstrated the maximum inhibition rate (56.42 ± 2.38 percent) at 1000 µg/mL concentration. This is respectable in comparison to the reference Acarbose (66.45 ± 1.78 percent). In contrast, turnip shoot extracts displayed the lowest α-glucosidase inhibition activity (38.27 ± 2.21 percent) at the same concentration. Conclusion: The current study demonstrated that the red dragon fruit pulp extract possesses substantial antihyperglycemic activity (α-amylase inhibition: 59.73 ± 4.33 percent, α-glucosidase inhibition: 56.42 ± 2.38 percent) in vitro, which could be a putative nutraceutical to manage postprandial hyperglycemia.
650 1 4 _aDIABETES MELLITUS
650 1 4 _aPOSTPRANDIAL HYPERGLYCEMIA
650 1 4 _aANTIDIABETIC ACTIVITY
650 1 4 _aΑ-AMYLASE
650 1 4 _aΑ-GLUCOSIDASE
650 1 4 _aACARBOSE
650 1 4 _aHYLOCEREUS POLYRHIZUS
650 1 4 _aBAMBUSA VULGARIS
650 1 4 _aBRASSICA RAPA L.
700 1 2 _aSarker, P.
700 1 2 _aSani, D. H.
700 1 2 _aMiah, M. F.
700 1 2 _aAlam, M. J.
856 4 0 _uhttps://drive.google.com/file/d/1MnOLMWFrfafEBzcXqTiFHgZpiRAZrqCE/view?usp=drive_link
_zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942 _2Loc
_cREF1
008 250602s9999 xx |||||s2 |||| ||und|d
999 _c55829
_d55829